Sandbox ID Genitourinary: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 14: Line 14:
::* '''Gonococcal Conjunctivitis'''
::* '''Gonococcal Conjunctivitis'''
:::* Preferred regimen: [[Ceftriaxone]] 1 g IM in a single dose
:::* Preferred regimen: [[Ceftriaxone]] 1 g IM in a single dose
::* '''Disseminated Gonococcal Infection (DGI)'''


 
:::* Preferred regimen: [[Ceftriaxone]] 1 g IV/IM every 24 hours
 
:::* Alternative regimen: [[Cefotaxime]] 1 g IV every 8 hours {{or}} [[Ceftizoxime]] 1 g IV every 8 hours
:::* All of the preceding regimens should be continued for 24--48 hours after improvement begins, at which time therapy can be switched to cefixime 400 mg orally twice daily to complete at least 1 week of antimicrobial therapy. No treatment failures have been reported with the recommended regimens.


----
----

Revision as of 14:50, 26 May 2015

  • Preferred regimen: Azithromycin 1 g orally in a single dose OR Ceftriaxone 250 mg intramuscularly (IM) in a single dose) OR Ciprofloxacin 500 mg orally twice a day for 3 days OR Erythromycin base 500 mg orally three times a day for 7 days
  • Ciprofloxacin is contraindicated for pregnant and lactating women.

  • Uncomplicated Gonococcal Infections of the Cervix, Urethra, and Rectum
  • Uncomplicated Gonococcal Infections of the Pharynx
  • Gonococcal Conjunctivitis
  • Disseminated Gonococcal Infection (DGI)
  • Preferred regimen: Ceftriaxone 1 g IV/IM every 24 hours
  • Alternative regimen: Cefotaxime 1 g IV every 8 hours OR Ceftizoxime 1 g IV every 8 hours
  • All of the preceding regimens should be continued for 24--48 hours after improvement begins, at which time therapy can be switched to cefixime 400 mg orally twice daily to complete at least 1 week of antimicrobial therapy. No treatment failures have been reported with the recommended regimens.



References

  1. 1.0 1.1 Workowski KA, Berman S, Centers for Disease Control and Prevention (CDC) (2010). "Sexually transmitted diseases treatment guidelines, 2010". MMWR Recomm Rep. 59 (RR-12): 1–110. PMID 21160459.
  2. Centers for Disease Control and Prevention (CDC) (2012). "Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections". MMWR Morb Mortal Wkly Rep. 61 (31): 590–4. PMID 22874837.